From Breakthrough to Blockbuster: The Business of Biotechnology, a new book co-authored by Nektarios Oraiopoulos, Associate Professor at Cambridge Judge Business School, shows how small, inexperienced entrepreneurial companies making up the biotech industry have created more life-changing medicines than all of the large pharmaceutical companies combined.
As Oraiopoulos explains: “The driving force was to bring together the complex reality of running a biotech company with the insights offered by the academic literature.”
Read the full article [Indiaeducationdiary.in]
Comments